TREA

98115520 - LIVIMMUNE

Follow

Information

  • Trademark
  • 98115520
  • Serial Number
    98115520
  • Filing Date
    August 03, 2023
    a year ago
  • Transaction Date
    February 06, 2025
    5 days ago
  • Status Date
    February 05, 2025
    6 days ago
  • Published for Opposition Date
    June 11, 2024
    8 months ago
  • Location Date
    August 06, 2024
    6 months ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    GUTTADAURO, JULIE
  • Attorney Docket Number
    230042.234
    Attorney Name
    Jared M. Barrett
    Law Office Assigned Location Code
    L60
  • Owners
Information
Mark Drawing Code
4
Mark Identification
LIVIMMUNE
Case File Statements
  • GS0051: Therapeutic preparations, namely, therapeutic preparations for the treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19, and therapeutic preparations for the prevention of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor
  • GS0441: Providing health and medical information, and providing health and medical information in the nature of providing a website featuring information in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; providing a website featuring medical information; providing a website featuring medical information in the field of antibodies for use in targeting the CCR5 cell receptor; medical analysis services, namely, medical analysis services in the field of antibodies for use in targeting the CCR5 cell receptor, and medical analysis services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19
  • GS0421: Scientific research consulting services, namely, scientific research consulting services in the field of immunology, and scientific research consulting services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services, and medical research services in the field of therapeutic agents, preparations and substances for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, immune system related diseases and disorders, respiratory diseases and disorders, COVID-19; medical research services in the field of antibodies for use in targeting the CCR5 cell receptor
Case File Event Statements
  • 4/4/2024 - 10 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/7/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/1/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/6/2024 - 9 months ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/22/2024 - 8 months ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/11/2024 - 8 months ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/11/2024 - 8 months ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/6/2024 - 6 months ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 2/5/2025 - 6 days ago
    9 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 2/5/2025 - 6 days ago
    10 - SOU EXTENSION 1 FILED Type: EXT1
  • 2/6/2025 - 5 days ago
    11 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 2/6/2025 - 5 days ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA